ABSTRACT: Aging is a main risk factor for intervertebral disc (IVD) degeneration, the main cause of low back pain. FOXO transcription factors are important regulators of tissue homeostasis and longevity. Here, we determined the expression pattern of FOXO in healthy and degenerated human IVD and the associations with IVD degeneration during mouse aging. FOXO expression was assessed by immunohistochemistry in normal and degenerated human IVD samples and in cervical and lumbar IVD from 6-, 12-, 24-, and 36-month-old C57BL/6J mice. Mouse spines were graded for key histological features of disc degeneration in all the time points and expression of two key FOXO downstream targets, sestrin 3 (SESN3) and superoxide dismutase (SOD2), was assessed by immunohistochemistry. Histological analysis revealed that FOXO proteins are expressed in all compartments of human and mouse IVD. Expression of FOXO1 and FOXO3, but not FOXO4, was significantly deceased in human degenerated discs. In mice, degenerative changes in the lumbar spine were seen at 24 and 36 months of age whereas cervical IVD showed increased histopathological scores at 36 months. FOXO expression was significantly reduced in lumbar IVD at 12-, 24-, and 36-month-old mice and in cervical IVD at 36-month-old mice when compared with the 6-month-old group. The reduction of FOXO expression in lumbar IVD was concomitant with a decrease in the expression of SESN3 and SOD2. These findings suggest that reduced FOXO expression occurs in lumbar IVD during aging and precedes the major histopathological changes associated with lumbar IVD degeneration. Keywords: intervertebral disc; aging; FOXO Low back pain is the leading cause of physical disability and imposes a great burden on global health.
Low back pain is the leading cause of physical disability and imposes a great burden on global health. [1] [2] [3] Intervertebral disc degeneration (IDD) is the most common underlying cause of back pain in the older adults. [4] [5] [6] The pathophysiology of IDD is not well understood and there are no current treatments to prevent or ameliorate disease onset or progression. 2 Given the progressive increase in life expectancy worldwide, with a projected 1.5 billion people 65 years and older by 2050, 3 it has become a priority to identify the causes and mechanisms of IDD to identify new therapeutic targets and approaches.
The intervertebral disc (IVD) is the largest avascular organ in the body. It is comprised of the nucleus pulposus (NP) that is rich in extracellular matrix (ECM) proteins such as aggrecan and type II collagen and confers the resistance to compressive strength; the annulus fibrosus (AF) that is primarily composed of type I collagen and provides the necessary tensile strength to contain the NP; and the cartilaginous endplates (EP) that have a structure similar to articular cartilage. [7] [8] [9] [10] Aging, a wellestablished risk factor for IDD, [11] [12] [13] is caused in part by accumulation of damaged organelles and macromolecules, leading to cell senescence, cell death, tissue dysfunction, and limited regenerative capacity of the tissues. 14, 15 Unlike any other connective tissues, IDD begins early in life and involves a cascade of changes at the cellular and molecular level that results in structural and functional alterations, leading to biomechanical failure and degeneration. 9, [16] [17] [18] [19] These early changes include accumulation of molecular damage in the main components of the extracellular matrix (ECM), 8 as well as in DNA 20 and proteins, 21 and are thought to be the consequence of defective homeostatic mechanisms that might trigger the onset of IDD. 10 However, IDD pathophysiology is not well understood and the early molecular events that lead to disruption of cell homeostasis and result in accumulation of molecular damage remain to be discovered.
The FOXO proteins are an evolutionarily conserved family of transcription factors with important functions in development, aging, and longevity. 22 In mammals, the FOXO family has four members (FOXO1, FOXO3, FOXO4, and FOXO6) with distinct and overlapping functions.
23 FOXO1, FOXO3, and FOXO4 are ubiquitously expressed whereas FOXO6 expression is restricted to neuronal tissues. 24 FOXO control of cellular homeostasis is mediated by regulation of cellular responses to stress. 24, 25 FOXO expression and activity are induced under oxidative stress conditions 24 and FOXO transcriptionally induce several antioxidant enzymes such as catalase and manganese superoxide dismutase. 26, 27 FOXO proteins also regulate two major intracellular clearance mechanisms, autophagy and the ubiquitin-proteasome system, to eliminate damaged and aggregated proteins. 25 Dysregulation of FOXO expression or activity contributes to the pathogenesis of age-related diseases in several different tissues, including bone 28, 29 and muscle. 30, 31 Despite FOXO are key regulators of cell homeostasis and aging, their expression and function in IVD have not yet been studied.
Here, we examined for the first time the expression of FOXO in human and mouse IVD and compared the changes in FOXO expression with key histological and molecular features of IDD in mouse spines spanning the entire adult age spectrum.
METHODS

Human Samples
Human lumbar IVD samples were collected from four cadaveric donors (age 40-45, mean 43 AE 3) without any known spine pathology and from four donors (age 53-74, mean 62 AE 10) undergoing spinal fusion surgery. Macroscopic assessment of disc degeneration in the cadaveric samples was performed according to Thompson grading. 32 Additional details of the samples are listed in Table 1 .
Mouse Samples
All animal experiments were performed in compliance with protocols approved by the Institutional Animal Care and Use Committee at our institution. Male C57BL/6J mice were housed in a temperature-controlled environment with a 12:12 h light/dark cycle and free access to food and water. Eight mice per age group were euthanized at 6, 12, 24, and 36 months of age, and the cervical and lumbar regions of the spine were collected for histology or gene expression analysis.
Histological Analysis
Human and mouse samples were washed in phosphatebuffered saline (PBS) and fixed using zinc-buffered formalin (ZFix, Anatech, Battle Creek, MI) for 48 h. After fixing, samples were decalcified in a Shandon TBD-2 decalcifier (Thermo Scientific, Waltham, MA) for 24 h on a shaker, thoroughly washed with PBS and embedded in paraffin. Four-micrometer-thick sections were cut and stained with Safranin O-fast green. In mouse spines, histological analysis of C3/C4 and L4/L5 IVD was performed as follows. Degenerative changes in NP and AF were graded following the system described by Masuda et al. 33 whereas changes in EP were scored according to the grading system described by Boos et al. 34 Samples were graded by two different observers blinded to the experimental conditions. Overall disc height, NP and AF cellularity, and the area of NP occupied by cells were measured in images obtained under 20Â magnification using ImageJ software.
Immunohistochemistry (IHC)
IHC was performed in human and mouse samples as described previously. 35 Briefly, 4-mm-thick sections were deparaffinized, rehydrated, and incubated with 2.5 mg/ml of hyaluronidase for 60 min at 37˚C. The sections were blocked with 10% goat serum for 1 h at room temperature followed by an overnight incubation with primary antibodies against FOXO1 (1:250, Abcam, Cambridge, MA, ab70382), FOXO3 (1:500, Abcam, ab70315), FOXO4 (1:500, Abcam, ab63254), SOD2 (1:500, StressMarq Biosciences, Victoria, Canada, SPC-118), SESN3 (1:100, Proteintech, 24532-1-AP) at 4˚C. After washing, sections were incubated with ImmPRESS DAB Reagent (Vector Laboratories, Burlingame, CA) for 30 min at room temperature followed by a 2-min incubation with DAB Peroxidase (HRP) Substrate Kit (Vector Laboratories). Stained samples were mounted and visualized under optical microscopy and images of the C3/C4 and L4/L5 IVD were obtained under 20Â magnification. Specificity of the FOXO1, FOXO3, and FOXO4 antibodies was assessed in mouse lumbar spine samples containing blood vessels, bone marrow, and spinal cord, respectively (Supplementary 
RNA Isolation and Gene Expression Analysis
Mouse lumbar spine samples were collected at 6 and 12 months of age, NP and AF from lumbar discs were resected separately and homogenized in Qiazol Lysis Reagent (Qiagen, Beverly, MA). RNA was isolated using Directzol RNA miniprep kit (Zymo Research, Irvine, CA). Gene expression was measured by real-time PCR using predesigned TaqMan gene expression assays (Thermo Scientific) for mouse Foxo1, Foxo3, Sod2, and Sesn3. Gapdh was used as reference gene.
Statistical Analysis
Data are reported as the mean AE 95%CI (95% confidence interval). Differences between groups were assessed by one-way analysis of variance (ANOVA) followed by a post hoc Tukey test. Comparisons between two groups were assessed by an unpaired, two-tailed t-test after testing for equal variance using an F-test. All statistical analyses were performed using Prism 6 software (GraphPad Software). p-values less than 0.05 were considered significant.
RESULTS
FOXO Expression in Human IVD
To determine the expression pattern of FOXO transcription factors in human IVD, IHC analysis was performed in normal and degenerated IVD for FOXO1, FOXO3, and FOXO4 isoforms. Normal human IVD showed strong expression for all FOXO isoforms in the nucleus pulposus (NP), inner (IAF), and outer annulus fibrosus (OAF) (Fig. 1 ). FOXO1 and FOXO3 immunostaining was present in more than 70% of cells whereas FOXO4 positive cells were less abundant at about 40%. Discs from donors undergoing spinal fusion surgery for IDD exhibited histological abnormalities including fibrotic NP with some cell clusters, loss of NP/AF demarcation, small ruptures in the AF, and general disorganization of AF lamellar structure. In all degenerated discs, there was a significant decrease of FOXO1 and FOXO3 but not FOXO4 staining in the NP, IAF, and OAF ( Fig. 1A and B) . L3-L4  IV  53  Male  L5-S1  IV  54  Male  L4-L5  IV  66  Male  L4-L5  IV  74  Male  L4-L5  II  40  Male  L4-L5  II  45  Female  L4-L5  II  45  Female  L4-L5  II  49  Male   FOXO IN INTERVERTEBRAL DISC AGING Degenerative Changes in the Mouse Spine With Aging We collected mouse spines at several time points throughout the entire adult spectrum to allow a detailed temporal analysis of histological and molecular changes. To determine the aging-related pattern and tissue compartments in which changes occur, cervical and lumbar spine segments from 6-, 12-, 24-, and 36-month-old mice were stained with safranin-O and analyzed histologically. As shown in Figure 2 , cervical IVD from mice exhibited profound histological changes that are characteristic of severe IVD degeneration at 36 months and resulted in significantly higher histopathological scores. These changes included severely decreased cellularity, complete disruption of the NP/AF borders, an increase in NP fibrosis without an apparent loss of proteoglycan staining, ruptured fibers and general disorganization of the AF, thinning and ossification of the EP, and osteophyte formation. Histomorphometric analysis revealed a reduction in disc height (Fig. 2C) , cell density in NP and AF (Fig. 2D) , and area of NP occupied by cells (Fig. 2E) . In lumbar discs, mild degenerative changes were seen in some samples as early as 12 months of age and included loss of AF cellularity, decrease in EP thickness, and loss of proteoglycan staining in the EP. The degree of disc degeneration markedly increased at 24 and 36 months of age, and histopathological scores were much higher than those found in the cervical IVD (Fig. 3B ). In addition, there was a significant decrease in disc height (Fig. 3C) , NP, and AF cellularity (Fig. 3D) , and in the area of NP occupied by cells in 24-and 26-month-old mice when compared with 6-month-old controls (Fig. 3E) . These results indicate that there is an age-related degeneration of the mouse IVD that is more pronounced and has an earlier onset in the lumbar than in the cervical region of the spine.
Age-Related Decrease in FOXO Expression in the Mouse Intervertebral Disc Next, we investigated the temporal changes in FOXO expression and the relationship with tissue degeneration. In the cervical spine of normal mature 6-monthold mice, FOXO1 and FOXO3 staining was detected in all the IVD structures (Fig. 4A) . No staining for FOXO4 was detected. The NP and AF, FOXO1, and FOXO3 had a similar percentage of positive cells (46 AE 5 and 55 AE 18, respectively), whereas FOXO3 was more abundantly expressed in EP cells (31 AE 11) than FOXO1 (9 AE 4). With aging, FOXO expression in the NP and AF remained stable up to 24 months of age and markedly decreased in 36-month-old mice when compared with younger mice (Fig. 4C) .
When comparing the cervical and lumbar regions of the mouse spine, FOXO expression patterns showed substantial differences. The number of FOXO1 expressing cells in all IVD compartments of 6-monthold mice was higher in lumbar (NP/AF: 78 AE 13, EP: 50 AE 10) than in cervical (NP/AF: 46 AE 5, EP: 9 AE 4) discs (Fig. 5) . FOXO3 expression was similar in the NP and AF between the different spine regions studied (lumbar: 55 AE 17, cervical: 55 AE 18), but much higher in the EP of lumbar IVD (50 AE 10) when compared with cervical discs (9 AE 4). The pattern of FOXO expression with aging was also markedly different between cervical and lumbar discs. In lumbar IVD, there was already a significant reduction in FOXO1 and FOXO3 expression at 12 months of age when compared with 6-month-old controls (Fig. 5B) . This reduction in FOXO1 and FOXO3 expression by 12 months of age was corroborated at the RNA level by qPCR analysis (Supplementary Fig. S2A ). These findings indicate that FOXO expression is reduced with age in cervical and lumbar IVD, with a more pronounced and much earlier decline in lumbar than in cervical discs. In addition, the reduction in FOXO expression in lumbar spine precedes cell loss and degenerative changes in the IVD.
Decreased Expression of FOXO Targets in Mouse IVD With Aging
As FOXO expression was reduced in mouse IVD during aging, particularly in the lumbar discs, we determined whether this was associated with compromised FOXO function. For this purpose, we determined the expression of two canonical FOXO targets, SESN3 36 and SOD2, 27 which are important in cellular stress responses. SESN3 and SOD2 expression was detected predominantly in the NP of 6-month-old mice (Fig. 6A ). There was a significant reduction of SESN3 and SOD2 positive cells in the NP of 12-, 24-, and (Fig. 6B) . Quantitative PCR analysis revealed that SOD2 and SESN3 expression was also reduced at the mRNA level in the NP of 12-month-old mice compared with younger controls ( Supplementary  Fig. S2B ). These results suggest that the age-related reduction in FOXO expression in lumbar spine is accompanied by a reduction in important effectors of FOXO signaling.
DISCUSSION
This is the first study that analyzed the expression pattern of the FOXO family of transcription factors in IVD. Our data demonstrate that FOXO are expressed in all structures of human IVD, with FOXO1 and FOXO3 being the most abundant isoforms, and that there is a significant decrease in the expression of FOXO1 and FOXO3 in human degenerated discs. In addition, using a mouse model to explore in detail the temporal relationship between FOXO expression in cervical and lumber IVD and degenerative changes that occur with aging, we demonstrated that FOXO expression is reduced with aging in IVD and that this event precedes major histological features of disc degeneration in the lumbar spine.
The first finding of our study is that FOXO are constitutively expressed in all structures of human and mouse IVD, particularly in NP and AF. Cells within the IVD reside in a unique biological niche since the avascular nature of disc tissue results in a hypoxic environment with low glucose concentrations. 37 Under these circumstances, NP and inner AF cells have evolved to be exquisitely adapted to hypoxia, mainly mediated by a constitutive activation of HIF-1 (hypoxia-inducible factor 1). 37 However, it is likely that additional pathways contribute to the adaptation of NP and AF cells to the IVD niche. FOXO transcription factors are associated with a wide range of biological processes that promote tissue and organismal homeostasis, including DNA repair, anti-oxidative defense, cell cycle arrest, and maintenance of proteostasis. 24, 38 Importantly, FOXO are key factors in the 
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ALVAREZ-GARCIA ET AL. cellular response to hypoxia 39 and energy stress. 40 Therefore, it is likely that a constitutive FOXO expression is an important mechanism to facilitate cell survival in the unique disc environment, and further supports the notion that loss of FOXO during aging may contribute to the pathophysiology of IDD. Aging is considered to have a major role in IDD. 41 IDD begins as early as the second decade of life and greatly increases in incidence with advancing age. 34, 41 Over the last decades, there has been substantial progress in identifying age-related changes in the IVD and in characterizing the catabolic events that occur during disc degeneration. 19, 34, 42, 43 However, as disc aging and disc degeneration can be viewed as two different processes, the challenge is to identify changes that are characteristic of disc aging and understand how they differ from pathologic degeneration. With this purpose, Vo et al. have recently organized the biochemical cascade of IVD aging into three distinct phases: Accumulation of damage to biomolecules, aberrant cellular response to damage, and loss of biologic structure and function. 11 Whereas the latter two phases have substantial overlap between physiological aging and disc degeneration, it is the first phase that has a unique component related to aging. This phase is characterized by an accumulation of damage to DNA and proteins that are likely a result from exposure to an oxidative and inflammatory environment. [44] [45] [46] The rate and extent of this accumulation of biomolecular damage is likely to drive the early stages of IDD and can be influenced by defective homeostatic mechanisms, environmental factors, and genetics. 11 This notion is in keeping with the general paradigm of aging that considers aging as a timedependent accumulation of cellular damage. 14, 15 In this regard, it is important to note that the ability of FOXO to promote longevity in model organisms has been linked to proteotoxic stress resistance, DNA damage repair, and enhancement of antioxidant defenses. 15, 24, 38, 47 A strength of the present study is the use of a mouse model spanning the entire adult age spectrum to characterize the age-related changes in cervical and lumbar IVD. Animal models of human diseases are vital for research aimed at identifying disease mechanisms and novel targets for therapeutic prevention and treatment. Most of the studies in disc degeneration utilize surgically manipulated animal models to create IDD-like changes. 33, [48] [49] [50] [51] A limitation of these approaches is that they do not recapitulate the changes that are characteristic of age-related disc degeneration. Here, we showed for the first time that lumbar and cervical discs in the mouse spine undergo degenerative changes with aging that resemble those present on human discs, including narrowing of the disc space, reduced cellularity, disappearance of the NP/AF interface, disorganization of the lamellar structure of the AF, EP ossification, and osteophyte formation. 34 Moreover, degenerative changes in mouse lumbar IVD were more severe and developed much earlier than those of the cervical spine. This observation is in keeping with the higher susceptibility for disc degeneration in human lumbar discs than other regions of the spine. 41, 52 These striking similarities are despite the differences between both species, that include size, biomechanical properties (biped vs. quadruped), nutrient diffusion due to disparity in disc size and the presence of notochordal cells in adult mouse discs. 44 Our data thus validate the mouse as a spontaneous model of age-related disc degeneration and provides a temporal pattern of major histological changes that constitute a valuable reference for basic spine research.
In the present study, we showed a reduction in FOXO expression in mouse lumbar IVD during early aging, before macroscopic degenerative changes are observed. These findings suggest that a reduction in FOXO expression and activity may have a deleterious impact on cell homeostasis during early stages of disc aging, and might result in an accelerated rate of biomolecular damage accumulation. Further supporting this rationale, our data show an age-related reduction in the expression of SESN3 and SOD2 of mouse lumbar discs. SESN are a family of highly conserved stress-responsive proteins that protect cells from oxidative stress and have been shown to delay aging-associated pathologies in model organisms. 53 On the other hand, SOD2 is the major mitochondrial antioxidant protein and plays a key role in regulating oxidative stress resistance. 54 Therefore, a reduction in the expression of these important proteins would compromise the ability of IVD cells to neutralize reactive oxygen species, potentially resulting in increased oxidative damage. A limitation of our study is that the analysis of FOXO expression in human IVD compared samples from young healthy individuals and old donors with disc degeneration. In this regard, the reduction in FOXO expression observed in our human samples could be either a consequence of not being produced by the aging cells and/or to loss of cellularity. Further studies comparing healthy and degenerated discs from different age groups are needed to elucidate the precise expression patterns of FOXO in IVD during aging and degeneration. In addition, while the present findings are the first to demonstrate a correlation between age-related decrease in FOXO expression and disc structural damage in the mouse, a causal relationship needs to be established. This limitation should be addressed in future studies using mouse models with tissue-specific FOXO deletion or overexpression to fully define FOXO function in IVD homeostasis, aging and degeneration.
Therapies aimed at preserving healthy joints during aging have become an appealing strategy to prevent musculoskeletal diseases on the elderly population, including IDD. To achieve this goal, it is of crucial importance to identify the precise pathways or mechanisms that lead to the initiation of the biochemical cascade that progressively leads to IDD. In the present study, we showed that the FOXO family of transcription factors is expressed in human and mouse IVD. Importantly, we showed a reduction in FOXO expression with aging in mouse lumbar IVD, preceding major histopathological changes associated with IDD. The aging related decline in FOXO is potentially an early initiating event in IDD and may constitute a novel biomarker and a future therapeutic target for prevention and treatment of the disease.
AUTHORS' CONTRIBUTIONS
OA had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. OA, KM, and MKL, designed research; OA, TM, and MO performed research; OA, KM, and MKL analyzed data; and OA and MKL wrote the paper. All authors read and approved the final version of the manuscript. 
